TopStocks.com - Premium Stock Alerts

    Sponsored

    TopStocks Alert: (Nasdaq:ALBT)

    July 15, 2026

    Greetings Readers,

    A Nasdaq diagnostics company trading at roughly a $6 million market cap with a low float of just 3.87 million shares is executing on multiple fronts: FDA-registered device launched in the UK, institutional wellness programs deploying the device for real-world validation, cannabis breathalyzer in development, and CAR T/CAR NK patents secured through 2040 in China and Hong Kong.

    The company is expanding into the UK, partnering with wellness organizations for first responder programs, developing cannabis impairment detection devices, and securing patent protection through 2040 for bispecific CAR T and CAR NK technology in China and Hong Kong.

    Now add a public float of just 3.87 million shares, multiple active partnerships, and a pipeline spanning consumer diagnostics to breakthrough cell therapy platforms, and you'll see exactly why this micro-cap profile is demanding attention.

    Here's what's happening with this micro-cap Nasdaq name:

    Avalon GloboCare Corp. (NASDAQ: ALBT)

    Avalon GloboCare is a precision diagnostics and biotechnology company developing consumer health technologies and next-generation cellular therapies. The company's lead commercial asset, KetoAir™️, is an FDA-registered Class I medical device designed for metabolic health monitoring through breath acetone measurement.

    KetoAir™️ is engineered to provide real-time insights into fat metabolism and ketosis, helping users optimize ketogenic diets for weight loss, athletic performance, and therapeutic applications. Its nanosensor technology delivers lab-quality measurements through a handheld breathalyzer connected to mobile apps.

    And based on multiple catalysts now taking shape, ALBT has secured a top position on my watchlist heading into 2026.

    Breaking News: Avalon GloboCare Announces $19.5M Acquisition Of AI Video Technology Firm

    Avalon GloboCare has completed a major strategic acquisition, purchasing RPM Interactive, a generative AI publishing and software company, in a $19.5 million all-stock transaction. As a result of this deal, the Company believes its stockholders' equity now exceeds the $2.5 million minimum required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1).

    Under the terms of the merger agreement, RPM was merged into a newly formed wholly owned subsidiary, Avalon Quantum AI, LLC, and Avalon issued 19,500 shares of Series E Non-Voting Convertible Preferred Stock valued at $1,000 per share, convertible into common stock at $1.50 per share beginning May 12, 2026, subject to customary conditions and limits.

    The acquisition brings RPM's Catch-Up SaaS platform into Avalon's ecosystem, a fully automated generative AI system that sources relevant clips, generates human-like AI commentary, creates engaging on-screen avatars, and publishes finished content across major platforms. Avalon plans to leverage this technology to support and amplify marketing initiatives for KetoAir and its broader consumer health portfolio beginning early next year.

    As part of the transaction, RPM's CEO Michael Mathews has been appointed to Avalon's Board of Directors, bringing more than two decades of experience in AI-enabled systems and digital media growth strategies.

    Source for Full PR: Avalon GloboCare Corp.

    What This Means For Investors

    This acquisition may represent a turning point for ALBT as it brings several important dynamics into play:

    • Nasdaq Compliance Path Strengthened: With stockholders' equity now believed to exceed the Nasdaq minimum requirement for continued listing, Avalon removes a major overhang that has pressured the stock, improving visibility and reducing delisting risk.
    • AI Powered Marketing Could Drive Product Adoption: KetoAir is Avalon's lead commercial device, and the biggest challenge for consumer health devices is cost-effective audience growth. Integrating RPM's automated video engine can increase content volume, broaden reach, and accelerate direct-to-consumer conversions.
    • Expansion Beyond Diagnostics Into AI Software: The company now owns an AI-based publishing platform with potential licensing revenue opportunities across media, sports, finance, entertainment, and lifestyle sectors, diversifying the business beyond hardware and biotech.
    • Leadership Upgrade With Proven Tech Operator: Michael Mathews joining the Board gives ALBT a high-level executive with experience building and selling digital media companies, scaling AI-enabled content systems, and executing strategic growth plans.
    • New Synergies With Wellness Market Expansion: As KetoAir enters the UK market and institutional pilots expand, this AI content engine can drive higher awareness at lower cost. More exposure and product education create a stronger pathway for revenue growth.
    • Low Float Micro Cap Structure Creates Sensitivity To Catalysts: With only 3.87 million shares in the public float, ALBT remains highly responsive to news-driven momentum, and a $19.5 million strategic acquisition relative to a ~$6 million market cap places it in a unique valuation setup.

    Here Are the Key Catalysts Coming Into Focus:

    • A tightly held float of just 3.87 million shares creating significant volatility potential
    • International expansion with UK market entry and active distribution
    • Institutional wellness contracts with first responders creating real-world health outcome data
    • Cannabis breathalyzer development targeting law enforcement and workplace compliance markets
    • Bispecific CAR T and CAR NK patents secured in China and Hong Kong through 2040
    • Multiple revenue channels from consumer sales, B2B contracts, and potential IP licensing

    More on each of these in a moment.

    Company Breakdown: Avalon GloboCare Corp. (NASDAQ: ALBT)

    Avalon is a commercial-stage diagnostics company focused on advancing precision consumer health technology. The company's flagship product, KetoAir™️, is an FDA-registered breathalyzer designed for continuous metabolic monitoring through breath acetone detection.

    Traditional ketone monitoring requires invasive blood tests or unreliable urine strips. Many users struggle with accuracy and consistency, leading to poor adherence and suboptimal outcomes.

    Avalon aims to solve this.

    Why KetoAir™️ Could Be a Market Leader

    KetoAir™️ has a commercial-ready profile supported by FDA registration and active deployment. The device measures breath acetone concentration (BrAce), a biomarker of fat metabolism that correlates with nutritional ketosis. Breath testing is non-invasive, repeatable, and provides instant feedback.

    Key distinctions include:

    • FDA registration as a Class I medical device (3026284320)
    • Nanosensor-based VOC detection technology
    • Integration with Apple & Android platforms
    • Active deployment in wellness programs and consumer markets

    KetoAir™️ is being used in structured programs for first responders, athletes, and metabolic health clients, helping them track real-time physiological changes.

    Q3 2025: Commercial Traction Accelerates

    Nevada First Responder Wellness Initiative

    In August 2025, Avalon launched the "Nevada POOL/PACT Holistic Health Reset" program with Saga Health and SpecialtyHealth, Inc. Fifty first responders are using KetoAir™️ over a four-month initiative focused on metabolic, physical, and behavioral health improvements. Mid-program data shows measurable individual health progress.

    UK Market Entry

    On September 1, 2025, Avalon began commercial distribution of KetoAir™️ in the United Kingdom through KetoAir.uk, marking its first international market launch and demonstrating scalable global distribution.

    London Health Optimization Summit

    Avalon showcased KetoAir™️ at the London Health Optimization Summit on September 13–14, 2025, gaining visibility with wellness professionals and potential partners.

    Pipeline Expansion: Cannabis Breathalyzer & Cellular Therapy IP

    Avalon's expansion includes development of a cannabis breathalyzer using the same nanosensor technology powering KetoAir™️.

    Concurrently, Avalon has secured CAR T and CAR NK patents through 2040 in China and Hong Kong, covering bispecific anti-CD19 x CD22 technology.

    What This Means for Investors

    The Q3 developments validate Avalon’s ability to scale commercially while building high-value IP assets. The UK launch demonstrates international scalability, the Nevada program provides real-world outcome data, the cannabis breathalyzer targets a regulatory compliance market, and the CAR T/CAR NK patents offer long-term licensing opportunities.

    ALBT Potential Catalyst #1: Tightly Held Float

    With just 3.87M shares in the float, ALBT could see amplified volatility as new catalysts emerge.

    ALBT Potential Catalyst #2: International Expansion

    UK distribution is only the beginning — additional European markets could follow with minimal incremental cost, each representing new revenue channels.

    ALBT Potential Catalyst #3: Institutional Wellness Programs

    The Nevada program provides replicable proof-of-concept for municipal, corporate, and healthcare system contracts.

    ALBT Potential Catalyst #4: Cannabis Breathalyzer

    Cannabis legalization is creating urgent demand for real-time impairment testing. A validated breath solution could become a major commercial opportunity.

    ALBT Potential Catalyst #5: CAR T & CAR NK Intellectual Property

    Patents through 2040 provide licensing optionality in major Asian markets, representing long-term non-dilutive revenue potential.

    ALBT Recap: Five Potential Breakout Catalysts

    • Tightly held 3.87M float
    • International expansion beyond the UK
    • Institutional wellness adoption
    • Cannabis breathalyzer development
    • CAR T/CAR NK patents providing licensing value

    ALBT is now on the active watchlist. As developments emerge, updates will follow here.

    Add Avalon GloboCare Corp. (NASDAQ: ALBT) to your radar.

    Enjoyed this breakdown?

    Don't miss our next early stock alert.
    Join our SMS list and get real time picks sent straight to your phone the moment we release them.

    Get Instant SMS Alerts

    Fast, free, zero spam. Opt out anytime.

    By joining, you agree to receive recurring SMS alerts from TopStocks. Message and data rates may apply. Reply STOP to unsubscribe.

    MASTER LEGAL DISCLAIMER

    Last Updated: Nov 30, 2025

    Publisher: Relqo Media LLC (Wyoming, United States)

    Subject Company: Avalon GloboCare Corp. (ALBT)

    IMPORTANT SUMMARY — PLEASE READ FIRST

    This website and all affiliated digital materials are published by Relqo Media LLC, a Wyoming marketing agency that has been compensated in cash by YachtXotics Enterprises Inc. and Uptic Analytics LLC to produce and distribute promotional content regarding Avalon GloboCare Corp. (NASDAQ, ALBT). This communication is a paid advertisement, not a research report, not investment advice, and not an independent publication. Relqo Media is not a broker-dealer, investment adviser, or securities analyst. Investing in small-cap or microcap securities is highly speculative and may result in the complete loss of your investment. All viewers are strongly urged to consult with a licensed investment professional and perform their own due diligence.

    1. NATURE AND INTENT OF THIS COMMUNICATION

    Relqo Media LLC is a for-profit marketing agency engaged in paid promotional campaigns for public companies. The content we create is strictly commercial and is intended to generate temporary public awareness, visibility, and short-term market attention for the featured company. This material is not impartial. All readers should interpret our content as a paid commercial advertisement and not as an editorial, research article, or independent analysis. We produce advertisements, not investment research. These communications are not designed to provide factual evaluations of the company's business operations or investment merit.

    2. COMPENSATION FOR Avalon GloboCare Corp. (ALBT)

    Relqo Media LLC has been contracted by YachtXotics Enterprises Inc. and Uptic Analytics LLC to provide investor awareness and advertising services for Avalon GloboCare Corp. (NASDAQ, ALBT). These arrangements involve monetary compensation in exchange for creating and distributing promotional content across multiple digital channels.

    Relqo Media LLC has received or will receive the following compensation for ALBT promotional services:

    • $20,000 for a campaign running from November 30, 2025 through December 17, 2025 paid by Uptic Analytics LLC.
    • $14,200 for a campaign running from June 25, 2025 through June 26, 2025 paid by YachtXotics Enterprises Inc.
    • $10,000 for a campaign running from July 13, 2025 through July 14, 2025 paid by YachtXotics Enterprises Inc.
    • $20,000 for a digital campaign running from July 14, 2025 through July 15, 2025 paid by YachtXotics Enterprises Inc.

    YachtXotics Enterprises Inc., Uptic Analytics LLC, and or their affiliates may own, acquire, or sell securities of ALBT before, during, or after the promotional period. Uptic Analytics LLC currently owns shares of ALBT, which represents an additional material conflict of interest. Any ownership interests, whether past, present, or future, must be assumed to influence the promotional content distributed for this campaign. All promotional materials produced by Relqo Media LLC regarding ALBT should be viewed as biased, financially motivated content created for the benefit of the paying entities.

    Relqo Media LLC does not represent itself as a licensed broker-dealer, registered investment adviser, or financial analyst. Nothing in our content should be interpreted as investment advice, an offer to buy or sell securities, or a recommendation to engage in any investment activity.

    Readers should perform independent due diligence, consult with licensed financial professionals, and assume that any statements made about ALBT are materially influenced by compensation and the ownership interests of the paying clients.

    Neither Relqo Media LLC, YachtXotics Enterprises Inc., nor Uptic Analytics LLC guarantee the accuracy, timeliness, or completeness of the information provided. All parties disclaim any liability for investment losses that may occur as a result of reliance on our promotional materials.

    3. INTENDED AUDIENCE

    These Communications are directed solely to U.S.-based, self-directed investors who understand the risks of investing in microcap and Nasdaq-listed securities. The content is not intended for children, seniors, retirement accounts, or individuals with limited experience in securities trading. These Communications are not intended to guide investment for long-term portfolio management or financial planning purposes.

    4. NO ENDORSEMENT OR VERIFICATION OF COMPANY CLAIMS

    Relqo Media LLC does not, and has not, independently verified, investigated, audited, or substantiated any statements, representations, or claims made by the featured company, its officers, directors, employees, affiliates, agents, press releases, marketing materials, or any third-party sources.

    Any and all information regarding Avalon GloboCare Corp. (NASDAQ: ALBT)—including but not limited to business descriptions, operational updates, clinical trial progress, scientific data, partnerships, revenue projections, market opportunity estimates, or strategic plans—should be assumed to be unverified, unaudited, incomplete, potentially inaccurate, and subject to change without notice.

    We make no warranties or representations as to the truthfulness, accuracy, reliability, or completeness of such information, and you should not interpret our publication of these statements as an endorsement or confirmation of their validity.

    You should not rely on any company-provided claims, projections, or forward-looking statements for the purpose of making an investment decision. All such statements may be speculative, overstated, selectively presented, or based on assumptions that may never materialize.

    If you choose to invest, you do so entirely at your own risk, and you should conduct thorough, independent due diligence—including reviewing SEC filings, consulting licensed investment professionals, and obtaining independent verification of any material facts—before making any investment decision.

    5. MARKET INFLUENCE AND TRADING PATTERN EXPECTATION

    Historically, promotional campaigns for microcap and small-cap securities—particularly those driven by paid advertising—often cause temporary, artificial, and unsustainable increases in share price and trading volume. These movements are typically fueled by short-term speculative interest, promotional circulation, algorithmic trading activity, and momentum-based retail buying rather than any change in the underlying business, operations, or financial condition of the company.

    You should assume and expect that:

    • ALBT's share price may experience sharp, rapid, and potentially extreme increases during the period of active promotion;
    • Trading volume may spike dramatically due to speculative buying pressure, news catalysts amplified by promotional activity, and social media or online forum chatter;
    • Once buying interest subsides, selling begins, or the promotion ends—which may occur suddenly and without notice—the share price may decline precipitously, potentially returning to pre-promotion levels or lower, often within days or even hours; and
    • These price and volume movements are not reflective of intrinsic value and may have no correlation to the company's actual fundamentals or long-term business prospects.

    Past market behavior shows that such promotional price spikes are frequently followed by steep losses, which can be rapid and irreversible. If you purchase shares during or shortly after a promotional period, you should be prepared for the high probability of losing a substantial portion, or all, of your investment.

    By engaging with our content, you acknowledge and agree that you fully understand the speculative, volatile, and high-risk nature of securities subject to promotional activity, and you will not hold Relqo Media LLC responsible for any losses resulting from such trading patterns.

    6. NO RELIANCE – INVESTOR RESPONSIBILITY

    The burden of research, verification, and risk assessment rests entirely with you, the reader. All content produced and distributed by Relqo Media LLC is promotional in nature and should not be the basis for any investment decision. We are not responsible for your interpretation or use of the information contained herein.

    You are solely responsible for:

    • Reviewing and analyzing all publicly available information, including but not limited to SEC filings, audited financial statements, and official company disclosures;
    • Consulting with a licensed, qualified investment professional, attorney, or tax adviser before making any investment decision;
    • Understanding and accepting the risks inherent in microcap and early-stage public companies, which may include extreme volatility, illiquidity, lack of financial transparency, insider selling, share dilution, regulatory challenges, and business failure.

    We make no warranties or representations as to the accuracy, completeness, timeliness, or reliability of any information presented. Any data, figures, or statements regarding the featured company's business, market opportunity, future performance, or partnerships may be incomplete, outdated, or incorrect. You should assume that certain information is based on third-party sources we have not independently verified.

    By viewing our materials, you agree that:

    • You will not rely solely on our communications in making an investment decision;
    • You accept full responsibility for conducting independent due diligence; and
    • Relqo Media LLC and its affiliates will not be liable for any losses or damages arising from your reliance on our content.

    7. FORWARD-LOOKING STATEMENTS, ASSUMPTIONS, AND ACCURACY NOTICE

    Our materials may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as well as other predictive or aspirational language regarding future events, performance, or results. Words such as "anticipates," "expects," "intends," "plans," "believes," "may," "will," "should," "could," "projects," "estimates," "potential," and similar expressions are intended to identify such statements. These statements are inherently uncertain, based on current expectations, estimates, and assumptions that may prove to be incorrect, incomplete, or no longer applicable at the time you read them.

    Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. Such factors include, but are not limited to: changes in market conditions, regulatory decisions, the outcome of clinical trials, competitive pressures, the availability of financing, and broader economic or geopolitical developments.

    Additionally, some information presented in our content is derived from third-party sources, company press releases, or statements from officers, directors, or affiliates of the featured company. We do not independently verify or guarantee the accuracy, completeness, or timeliness of such information. Any claim, projection, or forward-looking statement should be considered purely speculative and potentially outdated..

    You should not place undue reliance on forward-looking statements or assume that they will prove to be accurate. Relqo Media LLC undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events, changes in circumstances, or the emergence of new information, except as required by law.

    8. INFORMATION SOURCING, BIAS, AND ACCURACY

    We use publicly available information including company websites, press releases, and promotional materials supplied by paying clients or related parties. We do not verify or validate this data.

    Assume all information presented by Relqo Media is:

    • Subjective,
    • Not independently verified,
    • Created to highlight potential upside and omit downsides,
    • Not suitable as the basis for any investment decision.

    9. OWNERSHIP AND TRADING CONFLICTS

    Relqo Media LLC, its contractors, members, and affiliates may hold or acquire shares in the companies we promote, including ALBT. We may buy or sell such shares without prior notice. These transactions may occur before, during, or after a promotional campaign and may affect market pricing. We are not obligated to update readers on our trading activity or affiliate holdings.

    10. MARKETING TOOLS, DATA COLLECTION, AND USER CONSENT

    We use a range of outreach and promotional tools, including:

    • Email and newsletter distributions,
    • SMS/MMS text campaigns,
    • Social media posts and influencers,
    • Google and native display ads,
    • Press releases, video marketing, and paid content distribution.

    By engaging with our content, you consent to receive ongoing marketing communications. You may unsubscribe, but your data may be retained for audit or compliance purposes. Please refer to our Privacy Policy for further details.

    11. ADVERTISING LAW COMPLIANCE

    Relqo Media LLC produces promotional content in accordance with the advertising disclosure standards set forth by the Federal Trade Commission (FTC) and the SEC's interpretations of sponsored investment-related communications.

    We make good-faith efforts to disclose all:

    • Compensation arrangements,
    • Conflicts of interest,
    • Risks,
    • Limitations of our role, and
    • The promotional nature of this content.

    We do not provide investment recommendations under any regulatory framework including, but not limited to, SEC Regulation Analyst Certification, FINRA Rule 2210, or Regulation Best Interest.

    12. NON-U.S. USERS

    This material is intended solely for distribution within the United States. If you are accessing this site from outside the U.S., you are responsible for complying with your country's laws. Relqo Media disclaims liability for access from non-U.S. jurisdictions where investor promotion, marketing, or solicitation of securities is restricted or prohibited.

    13. DISCLAIMER OF WARRANTIES AND LIMITATION OF LIABILITY

    All content is provided "as-is" and without warranties of any kind, either express or implied. Relqo Media LLC disclaims any and all liability for:

    • Investment losses,
    • Inaccuracies,
    • Technical delays,
    • User misunderstandings,
    • Omissions or errors in content.

    Total liability for any claim shall not exceed one hundred dollars ($100).

    14. LEGAL GOVERNANCE AND DISPUTE RESOLUTION

    All matters arising out of this disclaimer shall be governed by the laws of the State of Wyoming. You agree that any dispute shall be resolved exclusively through binding arbitration under the rules of the American Arbitration Association, to be held in Sheridan County, Wyoming. Class action claims and group arbitration are expressly prohibited.

    15. NON-SOLICITATION AND GEOGRAPHIC LIMITATIONS

    Nothing in our content constitutes a general solicitation or a personal securities recommendation. If you reside in a jurisdiction where such communications are unlawful, you must exit this site and discontinue engagement with our content.

    16. FINAL NOTICE – ACCEPTANCE OF TERMS

    We reserve the right to update this Disclaimer at any time without notice. Your continued use of our services or content constitutes acceptance of the most recent version.

    If you do not accept all terms of this disclaimer in full, you must:

    • Exit our websites,
    • Unsubscribe from our communications,
    • Discontinue viewing all Relqo Media promotional content.

    17. NO RELIANCE

    By viewing or engaging with this content, you agree that:

    • You will not rely on any statements made by Relqo Media for investment purposes,
    • You waive any claim that our content was a material factor in your investment decision,
    • You have read, understood, and accepted this disclaimer in full.

    © 2024 Relqo Media LLC. All Rights Reserved.

    Legal Contact: 📧 support@topstocks.com

    Mailing Address: 1309 Coffeen Ave Ste 1200, Sheridan, WY 82801

    Affiliate Disclosure: Relqo Media LLC owns and operates TopStocks.com and all affiliated digital properties.